Yıl: 2017 Cilt: 27 Sayı: 4 Sayfa Aralığı: 56 - 57 Metin Dili: İngilizce İndeks Tarihi: 29-07-2022

Chronic Myeloid Leukemia After Chemoradiotherapy in a Patient with Non-Small Cell Lung Cancer

Öz:
-
Anahtar Kelime:

Konular: Onkoloji
Belge Türü: Makale Makale Türü: Editöre Mektup Erişim Türü: Erişime Açık
  • 1. Sant M, Allemani C, Tereanu C, et al. Incidence of hematologic malignancies in Europe by morphologic subtype: results of the HAEMACARE project. Blood 116: 3724-3734, 2010.
  • 2. Smith A, Howell D, Patmore R, et al. Incidence of haematological malignancy by sub-type: a report from the Haematological Malignancy Research Network. Br J Cancer 105: 1684-1692, 2010.
  • 3. Faderl S, Talpaz M, Estrov Z, et al. The biology of chronic myeloid leukemia. N Engl J Med 341: 164-172, 1999.
  • 4. Levine EG, Bloomfield CD. Leukemias and myelodysplastic syndromes secondary to drug, radiation, and environmental exposure. Semin Oncol 19: 47-84, 1992.
  • 5. Aguiar RC. Therapy-related chronic myeloid leukemia: an epidemiological, clinical and pathogenetic appraisal. Leuk Lymphoma 29: 17-26, 1998.
  • 6. Waller CF, Fetscher S, Lange W. Treatment-related chronic myelogenous leukemia. Ann Hematol 78: 341-354, 1999.
  • 7. Porta C, Casagranda I, Semino G, et al. Chronic myeloid leukemia following cyclophosphamide-containing chemotherapy in a breast cancer patient. Haematologica 78: 56-57, 1993.
  • 8. Buxhofer-Ausch V, Hinterberger-Fischer M, Hinterberger W. Bcr-abl positive blast crisis of chronic myeloid leukemia emerging in a case of metastatic colorectal cancer 3 months after completion of an 8-month course of cetuximab and irinotecan. Eur J Haematol 76: 447-448, 2006.
  • 9. Gokel Y, Paydas S. Chronic myeloid leukemia in a patient with colon adenocarcinoma. Haematologia (Budap) 32: 501- 503, 2002.
  • 10. Nakamura H, Inokuchi K, Hanawa H, et al. A case of chronic myeloid leukemia with minor bcr-abl transcript following fluorouracil therapy for esophageal carcinoma. Ann Hematol 79: 396-401, 2000.
  • 11. Baccarani M, Deininger MW, Rosti G, et al. European LeukemiaNet recommendations for the management of chronic myeloid leukemia: 2013. Blood 122: 872-884, 2013.
  • 12. Baccarani M, Cortes J, Pane F, et al. Chronic myeloid leukemia: an update of concepts and management recommendations of European LeukemiaNet. J Clin Oncol 27: 6041-6451, 2009.
  • 13. Kantarjian H, Shah NP, Hochhaus A, et al. Dasatinib versus imatinib in newly diagnosed chronic-phase chronic myeloid leukemia. N Engl J Med 362: 2260-2270, 2010.
  • 14. Saglio G, Kim DW, Issaragrisil S, et al. Nilotinib versus imatinib for newly diagnosed chronic myeloid leukemia. N Engl J Med 362: 2251-2259, 2010.
  • 15. Haznedaroglu IC. Current concerns of undertreatment and overtreatment in chronic myeloid leukemia based on European LeukemiaNet 2013 recommendations. Expert Opin Pharmacother 14: 2005-2010, 2013.
APA Demircioğlu S, KORKMAZ L, yılmaz s, Balta O, Ceneli O, ARTAÇ M (2017). Chronic Myeloid Leukemia After Chemoradiotherapy in a Patient with Non-Small Cell Lung Cancer. , 56 - 57.
Chicago Demircioğlu Sinan,KORKMAZ Levent,yılmaz seda,Balta Ozlen,Ceneli Ozcan,ARTAÇ Mehmet Chronic Myeloid Leukemia After Chemoradiotherapy in a Patient with Non-Small Cell Lung Cancer. (2017): 56 - 57.
MLA Demircioğlu Sinan,KORKMAZ Levent,yılmaz seda,Balta Ozlen,Ceneli Ozcan,ARTAÇ Mehmet Chronic Myeloid Leukemia After Chemoradiotherapy in a Patient with Non-Small Cell Lung Cancer. , 2017, ss.56 - 57.
AMA Demircioğlu S,KORKMAZ L,yılmaz s,Balta O,Ceneli O,ARTAÇ M Chronic Myeloid Leukemia After Chemoradiotherapy in a Patient with Non-Small Cell Lung Cancer. . 2017; 56 - 57.
Vancouver Demircioğlu S,KORKMAZ L,yılmaz s,Balta O,Ceneli O,ARTAÇ M Chronic Myeloid Leukemia After Chemoradiotherapy in a Patient with Non-Small Cell Lung Cancer. . 2017; 56 - 57.
IEEE Demircioğlu S,KORKMAZ L,yılmaz s,Balta O,Ceneli O,ARTAÇ M "Chronic Myeloid Leukemia After Chemoradiotherapy in a Patient with Non-Small Cell Lung Cancer." , ss.56 - 57, 2017.
ISNAD Demircioğlu, Sinan vd. "Chronic Myeloid Leukemia After Chemoradiotherapy in a Patient with Non-Small Cell Lung Cancer". (2017), 56-57.
APA Demircioğlu S, KORKMAZ L, yılmaz s, Balta O, Ceneli O, ARTAÇ M (2017). Chronic Myeloid Leukemia After Chemoradiotherapy in a Patient with Non-Small Cell Lung Cancer. Uluslararası Hematoloji-Onkoloji Dergisi, 27(4), 56 - 57.
Chicago Demircioğlu Sinan,KORKMAZ Levent,yılmaz seda,Balta Ozlen,Ceneli Ozcan,ARTAÇ Mehmet Chronic Myeloid Leukemia After Chemoradiotherapy in a Patient with Non-Small Cell Lung Cancer. Uluslararası Hematoloji-Onkoloji Dergisi 27, no.4 (2017): 56 - 57.
MLA Demircioğlu Sinan,KORKMAZ Levent,yılmaz seda,Balta Ozlen,Ceneli Ozcan,ARTAÇ Mehmet Chronic Myeloid Leukemia After Chemoradiotherapy in a Patient with Non-Small Cell Lung Cancer. Uluslararası Hematoloji-Onkoloji Dergisi, vol.27, no.4, 2017, ss.56 - 57.
AMA Demircioğlu S,KORKMAZ L,yılmaz s,Balta O,Ceneli O,ARTAÇ M Chronic Myeloid Leukemia After Chemoradiotherapy in a Patient with Non-Small Cell Lung Cancer. Uluslararası Hematoloji-Onkoloji Dergisi. 2017; 27(4): 56 - 57.
Vancouver Demircioğlu S,KORKMAZ L,yılmaz s,Balta O,Ceneli O,ARTAÇ M Chronic Myeloid Leukemia After Chemoradiotherapy in a Patient with Non-Small Cell Lung Cancer. Uluslararası Hematoloji-Onkoloji Dergisi. 2017; 27(4): 56 - 57.
IEEE Demircioğlu S,KORKMAZ L,yılmaz s,Balta O,Ceneli O,ARTAÇ M "Chronic Myeloid Leukemia After Chemoradiotherapy in a Patient with Non-Small Cell Lung Cancer." Uluslararası Hematoloji-Onkoloji Dergisi, 27, ss.56 - 57, 2017.
ISNAD Demircioğlu, Sinan vd. "Chronic Myeloid Leukemia After Chemoradiotherapy in a Patient with Non-Small Cell Lung Cancer". Uluslararası Hematoloji-Onkoloji Dergisi 27/4 (2017), 56-57.